"Ribonucleosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
| Descriptor ID |
D012263
|
| MeSH Number(s) |
D13.570.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ribonucleosides".
Below are MeSH descriptors whose meaning is more specific than "Ribonucleosides".
This graph shows the total number of publications written about "Ribonucleosides" by people in this website by year, and whether "Ribonucleosides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2020 | 2 | 1 | 3 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ribonucleosides" by people in Profiles.
-
Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2. Trials. 2021 Aug 23; 22(1):561.
-
Electron Density Analysis of SARS-CoV-2 RNA-Dependent RNA Polymerase Complexes. Molecules. 2021 Jun 28; 26(13).
-
[Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2]. Rev Esp Quimioter. 2021 Oct; 34(5):402-407.
-
Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infection. J Cell Physiol. 2021 09; 236(9):6597-6606.
-
Antiviral Activity of 7-Substituted 7-Deazapurine Ribonucleosides, Monophosphate Prodrugs, and Triphoshates against Emerging RNA Viruses. ACS Infect Dis. 2021 02 12; 7(2):471-478.
-
COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome? Am J Physiol Heart Circ Physiol. 2020 10 01; 319(4):H793-H796.
-
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting. Mol Cell. 2020 09 03; 79(5):710-727.
-
COVID-19: Rescue by transcriptional inhibition. Sci Adv. 2020 07; 6(27).
-
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels. Int J Biol Sci. 2020; 16(13):2382-2391.
-
COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2. In Vivo. 2020 Jun; 34(3 Suppl):1567-1588.